Furthermore, administration of the NLRP3 antagonist, MCC950, effectively alleviated FE-induced pulmonary edema, lipid peroxidation, and histopathological lung damage through blockade of the ERK cascade. The gene discussed is NLRP3; the disease is pulmonary edema.